secwatch.observer — SEC 8-K summary
======================================

Issuer:     Avidity Biosciences, Inc. (—)
CIK:        0001599901
Form:       8-K
Filed at:   2024-05-15T23:59:59+00:00
Accession:  0001193125-24-138959
Event type: leadership
Sentiment:  neutral
Materiality: 0.35
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Avidity Biosciences appoints former Roche SVP Simona Skerjanec as Class II director
--------------------------------------------------------------------------------

- Ms. Skerjanec, 59, former Senior Vice President and Global Neuroscience Head at Roche (2015-2023), appointed effective May 14, 2024.
- She fills the Class II vacancy resulting from Eric Mosbrooker's resignation in December 2023.
- She receives options vesting monthly over three years and cash compensation per the Non-Employee Director Compensation Program.
- Board determined she is independent under Nasdaq listing requirements.
- No arrangements or transactions requiring disclosure under Item 404(a) of Regulation S-K.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1599901/000119312524138959/0001193125-24-138959-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1599901/000119312524138959/d801929d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-24-138959

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer